Search results
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
Zacks via Yahoo Finance· 6 days agoBiogen's (BIIB) first-quarter earnings beat estimates but sales miss the mark. While sales of key...
AMPH- A Generic Drugmaker Looking to Expand Via Acquisition, Biosimilars Moves
MoneyShow via Yahoo Finance· 6 days agoAmphastar Pharmaceuticals Inc. (AMPH) is a generic drug company founded in 1996 that went public in 2014. Amphastar focuses on drugs ...
Biodexa gains license for polyposis asset as stock more than doubles
Pharmaceutical Technology via Yahoo Finance· 16 hours agoThe drug won US Food and Drug Administration (FDA) approval in 2021 for the treatment of adult...
4 Large Drug Stocks to Hold on to Amid Industry Challenges
Zacks via Yahoo Finance· 6 days agoDrug and biotech companies are likely to see significant innovation. In the Large-Cap...
BioMarin stock falls 9% in wake of Q1 report, pipeline updates
Seeking Alpha· 5 days agoBioMarin (BMRN) stock fell 9% Thursday, the day after the company released its Q1 earnings report...
White House Plan To Curb Drug Shortages Doesn’t Address Generics’ Quality
Forbes· 6 days agoDrug shortages are at an all-time high. The White House rolled out a plan earlier this month...
Is Eli Lilly Stock A Buy After Weight-Loss Drug Succeeds In Sleep Apnea Patients?
Investor's Business Daily· 5 days agoThe company also calls for adjusted earnings of $12.20 to $12.70 per share. Both measures...to bring...
Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray
Morningstar· 6 days agoBy Chris Wack Amneal Pharmaceuticals shares were up 9% after the Food and Drug Administration approved an abbreviated new drug application for over-the-counter ...
Is Bristol Myers Squibb Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 days agoAnd in Revlimid's case, it is already facing competition from generics. Revenue fell by 3% last year to just over $45 billion, the second straight...t...
Novartis raises forecasts as top drug sales beat Wall Street estimates
BioPharma Dive via Yahoo Finance· 7 days agoNovartis’ top-selling drugs Entresto and...continue this year, giving Novartis “confidence” to...